Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral L-arginine for pulmonary hypertension in thalassemia major
IRCT20191218045785N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in pulmonary hypertension (PH) and beta thalassemia major, sponsored by Shahrekord University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
arginine
03
Conditions
pulmonary hypertension (PH)beta thalassemia major
Beyond the preview
Go deeper on IRCT20191218045785N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191218045785N1.